Comparative analysis of cell-associated HIV DNA levels in cerebrospinal fluid and peripheral blood by droplet digital PCR

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  De Oliveira, Michelli Faria ^a   Gianella, Sara ^a   Letendre, Scott ^b   Scheffler, Konrad ^a,c   Pond, Sergei L Kosakovsky ^a   Smith, Davey M ^a,d   Strain, Matt ^a   Ellis, Ronald J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ARTICLE; BLOOD ANALYSIS; CELL COUNT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; DROPLET DIGITAL POLYMERASE CHAIN REACTION; FALSE POSITIVE RESULT; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYSIS; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; RNA ANALYSIS; VIRUS DETECTION; VIRUS REPLICATION; ANTIBODY SPECIFICITY; BLOOD; CD4+ T LYMPHOCYTE; CYTOLOGY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; PROCEDURES; RETROSPECTIVE STUDY; VIREMIA; VIROLOGY; VIRUS LOAD;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; CEREBROSPINAL FLUID; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, VIRAL; VIRAL LOAD; VIREMIA; VIRUS REPLICATION;

EID: 84947258722     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139510     Document Type: Article

References (25)

1. Schnell G, Price RW, Swanstrom R, Spudich S. Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection. J Virol. 2010; 84:2395-407. doi: 10.1128/JVI.01863-09 PMID: 20015984
2. Eriksson S, Graf EH, Dahl V, Strain MC, Yukl SA, Lysenko ES, et al. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog. 2013; 9:e1003174. doi: 10.1371/journal. ppat.1003174 PMID: 23459007
3. Alidjinou EK, Bocket L, Hober D. Quantification of viral DNA during HIV-1 infection: A review of relevant clinical uses and laboratory methods. Pathol Biol (Paris). 2014; 63:53-59.
4. Shiramizu B, Gartner S, Williams A, Shikuma C, Ratto-Kim S, Watters M, et al. Circulating proviral HIV DNA and HIV-Associated dementia. AIDS. 2005; 19:45-52. PMID: 15627032
5. Shiramizu B, Lau E, Tamamoto A, Uniatowski J, Troelstrup D. Feasibility Assessment of Cerebrospinal Fluid from HIV-1-Infected Children for HIV Proviral DNA and Monocyte Chemoattractant Protein 1 Alleles. J Investig Med. 2006; 54:468. PMID: 17169271
6. Agsalda-Garcia M, Shiramizu B, Melendez L, Plaud M, Liang CY, Wojna V. Different Levels of HIV DNA Copy Numbers in Cerebrospinal Fluid Cellular Subsets. J Heal Care Poor Underserved. 2014; 24:8-16.
7. Kamat A, Lyons JL, Misra V, Uno H, Morgello S, Elyse J, et al. Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection. J Acquir Immune Defic Syndr. 2012; 60:234-243. doi: 10.1097/QAI.0b013e318256f3bc PMID: 22569268
8. Burdo TH, Weiffenbach A, Woods SP, Letendre S, Ellis RJ, Williams KC. Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection. AIDS. 2013; 27:1-16.
9. Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, et al. Cerebrospinal Fluid Human Immunodeficien Virus Type 1 RNA levels are elevated in neurocognitively impaired individuals with Acquired Immunodeficiency Syndrome. Ann Neurol. 1997; 42:679-688. PMID: 9392566
10. Strain MC, Lada SM, Luong T, Rought SE, Gianella S, Terry VH, et al. Highly precise measurement of HIV DNA by droplet digital PCR. PLoS One. 2013; 8:e55943. doi: 10.1371/journal.pone.0055943 PMID: 23573183
11. Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, et al. Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System. Arch Neurol. 2009; 65:65-70.
12. Christopherson C, Kidane Y, Conway B, Krowka J, Sheppard H, Kwok S. PCR-Based Assay To Quantify Human Immunodeficiency Virus Type 1 DNA in Peripheral Blood Mononuclear Cells. J Clin Microbiol. 2000; 38:630-634. PMID: 10655358
13. Lafeuillade A, Poggi C, Pellegrino P, Corti K, Profizi N, Sayada C. HIV-1 replication in the plasma and cerebrospinal fluid. Infection. 1996; 24:367-371. PMID: 8923047
14. Neuenburg JK, Cho TA, Nilsson A, Bredt BM, Hebert SJ, Grant RM, et al. T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infection. J Acquir Immune Defic Syndr. 2005; 39:16-22. PMID: 15851909
15. Neuenburg JK, Furlan S, Bacchetti P, Price RW, Grant RM. Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy. AIDS. 2005; 19:1351-1359. PMID: 16103765
16. Schrier RD, Hong S, Crescini M, Ellis R, Pérez-Santiago J, Spina C, et al. Cerebrospinal Fluid (CSF) CD8+ T-Cells That Express Interferon-Gamma Contribute to HIV Associated Neurocognitive Disorders (HAND). PLoS One. 2015; 10:e0116526. doi: 10.1371/journal.pone.0116526 PMID: 25719800
17. Staprans SI, Hamilton BL, Follansbee SE, Elbeik T, Barbosa P, Grant RM, et al. Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med. 1995; 182:1727-1737. PMID: 7500017
18. Cusini A, Vernazza PL, Yerly S, Decosterd LA, Ledergerber B, Fux CA, et al. Higher CNS penetrationeffectiveness of long-term combination antiretroviral therapy is associated with better HIV-1 viral suppression in cerebrospinal fluid. J Acquir Immune Defic Syndr. 2013; 62:28-35. doi: 10.1097/QAI. 0b013e318274e2b0 PMID: 23018371
19. Burgard M, Izopet J, Dumon B, Tamalet C, Descamps D, Ruffault A, et al. HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment. AIDS Res Hum Retroviruses. 2000; 16:1939-47. PMID: 11153076
20. Avettand-Fenoel V, Prazuck T, Hocqueloux L, Melard A, Michau C, Kerdraon R, et al. HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term nonprogressors. AIDS. 2008; 22:1880-1882.
21. Choi JY, Hightower GK, Wong JK, Heaton R, Woods S, Grant I, et al. Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. J Neurovirol. 2012; 18:81-90. doi: 10.1007/s13365-011-0059-9 PMID: 22528397
22. Kiselinova M, Pasternak AO, De Spiegelaere W, Vogelaers D, Berkhout B, Vandekerckhove L. Comparison of droplet digital PCR and seminested real-time PCR for quantification of cell-Associated HIV-1 RNA. PLoS One. 2014; 9:e85999. doi: 10.1371/journal.pone.0085999 PMID: 24465831
23. Valcour VG, Ananworanich J, Agsalda M, Sailasuta N, Chalermchai T, Schuetz A, et al. HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients. PLoS One. 2013; 8:e70164. doi: 10. 1371/journal.pone.0070164 PMID: 23936155
24. Shiramizu B, Williams AE, Shikuma C, Valcour V. Amount of HIV DNA in Peripheral Blood is Proportional to the Severity of Neurocognitive Disorders. J Neuropsychiatry Clin Neurosci. 2009; 21:68-74. doi: 10.1176/appi.neuropsych.21.1.68 PMID: 19359454
25. Shiramizu B, Paul R, Williams A, Shikuma C, Watters M, Grove J, et al. HIV Proviral DNA Associated With Decreased Neuropsychological Function. J Neuropsychiatry Clin Neurosci. 2007; 19:157-163. PMID: 17431062